BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Rainer, S. R. Smallpox Vaccination Program Implementation Raises Concerns and Questions. N.J Nurse 2003, 33 (2): 8.
Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., and Miller, E. Herd Immunity From Meningococcal Serogroup C Conjugate Vaccination in
England: Database Analysis BMJ 2­15­2003, 326 (7385): 365­366.
Raufu, A. Polio Vaccine Plans May Run into Problems in Nigeria. BMJ. 327 (7410): 380; August 9, 2003.
Reinert, P. [Purulent Meningitis in Children: Special Considerations for Developing Countries]. Med.Trop.(Mars.). 63 (4­5): 481­485; 2003.
Reinert, P.; Soubeyrand, B.; Gauchoux, R. [35­Year Measles, Mumps, Rubella Vaccination Assessment in France]. Arch Pediatr. 10 (11): 948­954;
November, 2003.
Richardson, V. A New Approach to Childhood Vaccination. Nurse Pract. 28 (11): 14,54; November, 2003.
Riley, C.; Riley, S. Influenza and Pneumococcal Disease in the Community. Nurs.Stand. 18 (4): 45­51; October 8, 2003.
Ring, A.; Marx, G.; Steer, C.; Prendiville, J.; Ellis, P. Poor Uptake of Influenza Vaccinations in Patients Receiving Cytotoxic Chemotherapy. Int J Clin Pract.
57 (6): 542­543; July 2003.
Ringler, M., Gobel, G., Most, J., and Weithaler, K. Fully Vaccinated Children Are Rare: Immunization Coverage and Seroprevalence in Austrian School
Children. Eur J Epidemiol. 2003, 18 (2): 161­170.
Ritter, O.; Bonz, A.; Strotmann, J.; Langenfeld, H. [Myocardial Infarction After Influenza Vaccination]. Z.Kardiol. 92 (11): 962­965; November, 2003.
Robbins, J. B.; Schneerson, R.; Gotschlich, E. C.; Mohammed, I.; Nasidi, A.; Chippaux, J. P.; Bernardino, L.; Maiga, M. A. Meningococcal Meningitis in Sub­
Saharan Africa: the Case for Mass and Routine Vaccination With Available Polysaccharide Vaccines. Bull.World Health Organ. 81 (10): 745­750; 2003.
Roberts, R. J. Tuberculin Testing Before BCG Vaccination: Effect of Age on Adverse Effects Has Not Been Made Clear. BMJ. 327 (7420): 932; October 18,
2003.
Roth, Y., Chapnik, J. S., and Cole, P. Feasibility of Aerosol Vaccination in Humans. Ann.Otol.Rhinol.Laryngol. 2003, 112 (3): 264­270.
Rubins, K. and Relman, D. A. Images in Clinical Medicine. Progression of the Lesion at the Site of Inoculation After Smallpox Vaccination N.Engl.J Med. 1­
30­2003, 348 (5): 414.
Saika, S.; Suzuki, K.; Ichinohe, S. [Measles Antibody Followed After Measles Vaccination: Comparison With Gelatin Beads Agglutination (PA) Antibody,
Hemagglutination Inhibition (HI) Antibody and IgG­Avidity]. Kansenshogaku Zasshi. 77 (10): 809­814; October, 2003.
Salleras, L., Dominguez, A., and Cardenosa, N. Dramatic Decline of Serogroup C Meningococcal Disease in Catalonia (Spain) After a Mass Vaccination
Campaign With Meningococcal C Conjugated Vaccine Vaccine 1­30­2003, 21 (7­8): 729­733.
Salleras, L., Dominguez, A., and Cardenosa, N. Impact of Mass Vaccination With Polysaccharide Conjugate Vaccine Against Serogroup C Meningococcal
Disease in Spain Vaccine 1­30­2003, 21 (7­8): 725­728.
Samoilovich, E.; Roivainen, M.; Titov, L. P.; Hovi, T. Serotype­Specific Mucosal Immune Response and Subsequent Poliovirus Replication in Vaccinated
Children. J Med Virol. 71 (2): 274­280; October, 2003.
Samuelsson, K.; Blennow, M. [Parents Rely on Child Vaccinations. But at the Same Time They Distrust the Medical Establishment As Shown in a Qualitative
Study of Attitudes]. Lakartidningen. 100 (40): 3132­3135; October 2, 2003.
Sankar, P.; Schairer, C.; Coffin, S. Public Mistrust: The Unrecognized Risk of the CDC Smallpox Vaccination Program. Am.J.Bioeth. 3 (4): 22­25; 2003.
Santiago, E. M.; Lawson, E.; Gillenwater, K.; Kalangi, S.; Lescano, A. G.; Du, Quella G.; Cummings, K.; Cabrera, L.; Torres, C.; Gilman, R. H. A Prospective
Study of Bacillus Calmette­Guerin Scar Formation and Tuberculin Skin Test Reactivity in Infants in Lima, Peru. Pediatrics. 112 (4): e298; October, 2003.
Santoli, J. M.; Peter, G.; Arvin, A. M.; Davis, J. P.; Decker, M. D.; Fast, P.; Guerra, F. A.; Helms, C. M.; Hinman, A. R.; Katz, R.; Klein, J. O.; Koslap­
Petraco, M. B.; Paradiso, P. R.; Schaffner, W.; Whitley­Williams, P. N.; Williamson, D. E.; Gellin, B. Strengthening the Supply of Routinely Recommended
Vaccines in the United States: Recommendations From the National Vaccine Advisory Committee. JAMA. 290 (23): 3122­3128; December 17, 2003.
Sanz, J. C.; Fernandez, M.; Sagues, M. J.; Ramirez, R. [Laboratory Diagnosis of Parotiditis in the Post­Vaccination Era: New Strategies].
Enferm.Infecc.Microbiol Clin. 21 (7): 383­384; August, 2003.
Sarria­Santamera, A.; Timoner, J. Influenza Vaccination in Old Adults in Spain. Eur.J Public Health. 13 (2): 133­137; June 2003.
Sauerbrei, A.; Uebe, B.; Wutzler, P. Molecular Diagnosis of Zoster Post Varicella Vaccination. J Clin.Virol. 27 (2): 190­199; July, 2003.
Saurina, G.; Shirazi, S.; Lane, J. M.; Daniel, B.; DiEugenia, L. Myocarditis After Smallpox Vaccination: A Case Report. Clin.Infect.Dis. 37 (1): 145­146; July
1, 2003.
Saurina, G.; Shirazi, S.; Lane, J. M.; Daniel, B.; DiEugenia, L. Myocarditis After Smallpox Vaccination: a Case Report. Clin.Infect.Dis. 37 (1): 145­146; July
1, 2003.
Scheibner, V. Response to Leask and McIntyre's Attack on Myself As a Public Opponent of Vaccination. Vaccine. 22 (1): vi­ix; December 8, 2003.
Schlagenhauf, P. Focus Topic This Issue­­Accidents and Travel. Check Your Insurance!; Focus Topic This Issue­­W135 Meningococcal Disease and Travel;
MalariaBioterrorism: Policy Considerations; Travel Medicine; Travelers' Diarrhea; Other Travel­Associated Infectious Diseases; Vaccines and
Vaccinations. J Travel.Med. 10 (6): 364­367; November, 2003.
Schmidt, K. and Ernst, E. MMR Vaccination Advice Over the Internet Vaccine 3­7­2003, 21 (11­12): 1044­1047.
Schmitt, H. J., Booy, R., Weil­Olivier, C., Van Damme, P., Cohen, R., and Peltola, H. Child Vaccination Policies in Europe: A Report From the Summits of
Independent European Vaccination Experts Lancet Infect.Dis. 2003, 3 (2): 103­108.
Schneider, C. P.; McDonald, M. D. "The King of Terrors" Revisited: the Smallpox Vaccination Campaign and Its Lessons for Future Biopreparedness. J.Law
Med.Ethics. 31 (4): 580­589; 2003.
Schneider, J. Protection Against Infectious Diseases by DNA­Based Vaccination Strategies­­Lessons for Allergy Treatment? Arb.Paul Ehrlich Inst.Bundesamt
Sera Impfstoffe Frankf A M. (94): 300­303; 2003.
Schoenewald, C., Hughes, C., and Bohnert, L. Vaccine Information Statements. Are Federal Guidelines Being Followed? Adv.Nurse Pract. 2003, 11 (2): 63­
70.
Schott, M. and Seissler, J. Dendritic Cell Vaccination: New Hope for the Treatment of Metastasized Endocrine Malignancies. Trends Endocrinol.Metab 2003,
14 (4): 156­162.
Schroeder, B. M. ACIP Issues Guidelines on the Use of Smallpox Vaccine in a Pre­Event Vaccination Program. Am Fam.Physician. 68 (3): 554, 557­554,
558; August 1, 2003.
Schwartz, M. D. The United States Civilian Smallpox Vaccination Program: Have We Thought Through the Whole Issue? Pharmacotherapy 2003, 23 (3):
271­273.
Shaikh, I.; Omair, A.; Inam, S. N.; Safdar, S.; Kazmi, T.; Anjum, Q. National Polio Day Campaign in a Squatter Settlement Through Medical Students. J
Pak.Med.Assoc. 53 (3): 98­101; March 2003.
Shapiro, Y.; Shemer, J.; Heymann, A.; Shalev, V.; Maharshak, N.; Chodik, G.; Green, M. S.; Kokia, E. Influenza Vaccination: Reduction in Hospitalizations
and Death Rates Among Members of "Maccabi Healthcare Services" During the 2000­2001 Influenza Season. Isr.Med.Assoc.J. 5 (10): 706­708; October,
2003.
Shoji, H. and Kaji, M. The Influenza Vaccination and Neurological Complications. Intern.Med. 2003, 42 (2): 139.
Sibbald, B. US Hospitals Balking at Smallpox Vaccination. CMAJ. 4­15­2003, 168 (8): 1034.
Silverman, R. D.; May, T. Terror and Triage: Prioritizing Access to Mass Smallpox Vaccination. Creighton.Law Rev. 36 (3): 359­374; April, 2003.
Singh, M. B. and Bhalla, P. L. Hypoallergenic Derivatives of Major Grass Pollen Allergens for Allergy Vaccination Immunol.Cell Biol. 2003, 81 (1): 86­91.
Sipetic, S.; Vlajinac, H.; Kocev, N.; Radmanovic, S. The Belgrade Childhood Diabetes Study: Association of Infections and Vaccinations on Diabetes in
Childhood. Ann.Epidemiol. 13 (9): 645­651; October, 2003.
Sisk, J. E.; Whang, W.; Butler, J. C.; Sneller, V. P.; Whitney, C. G. Cost­Effectiveness of Vaccination Against Invasive Pneumococcal Disease Among People
50 Through 64 Years of Age: Role of Comorbid Conditions and Race. Ann.Intern.Med. 138 (12): 960­968; June 17, 2003.